Order results by:
| Issue | Title | |
| Vol 14, No 1 (2018) | STUDY OF CLINICAL EFFICACY OF ORIGINAL AND GENERIC DRUGS OF IVABRADINE IN PATIENTS WITH STABLE ANGINA (СOMPARATIVE STUDY) | Abstract similar documents |
| S. V. Povetkin, Ju. V. Luneva | ||
| "... 83.0±6.18 to 67.6±5.97 beats/min in the 2nd group, p<0.01 for both) and in blood pressure level ..." | ||
| Vol 5, No 3 (2009) | EFFICACY OF IVABRADINE AND VERAPAMIL IN PATIENTS WITH DIASTOLIC HEART FAILURE CAUSED BY LEFT VENTRICLE IMPAIRED RELAXATION | Abstract similar documents |
| K. G. Adamyan, A. L. Chilingarian | ||
| "... Aim. To compare ivabradine (IB) and verapamil (VP) effects on left ventricle (LV) diastolic ..." | ||
| Vol 8, No 5 (2012) | ASSESSMENT OF THE CHANGES IN BLOOD PRESSURE CIRCADIAN PROFILE AND VARIABILITY IN PATIENTS WITH CHRONIC HEART FAILURE AND ARTERIAL HYPERTENSION DURING COMBINED THERAPY INCLUDING IVABRADINE | Abstract similar documents |
| M. V. Surovtseva, N. A. Koziolova, A. I. Chernyavina | ||
| "... on received drugs: perindopril and ivabradine - group 1; perindopril, bisoprolol and ivabradine - group 2 ..." | ||
| Vol 13, No 2 (2017) | POSSIBILITIES OF IVABRADINE, A SELECTIVE INHIBITOR OF ION F-CHANNELS OF SINUS NODE, IN PREVENTION OF ANTHRACYCLINE CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER | Abstract similar documents |
| Yu. V. Vasyuk, V. V. Nesvetov, E. L. Shkolnik, L. D. Shkolnik, G. V. Varlan, G. E. Gendlin, E. I. Emelina | ||
| "... ) and persisted until the 6th month (74.2±14.9 beats/min, p<0.001). In the main group, the frequency of complaints ..." | ||
| Vol 17, No 6 (2021) | Damage to the Cardiovascular System in Patients with SARS-CoV-2 Coronavirus Infection. Part 1: Predictors of the Development of an Unfavorable Prognosis | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, I. I. Shvedov, E. E. Bykova, A. A. Ivannikov, L. V. Vasilyeva | ||
| "... .018), increased the likelihood of mechanical ventilation use (OR 1.451, CI 1.168-1.803, p<0.001) and stay ..." | ||
| Vol 11, No 5 (2015) | Comparative efficacy of amiodarone with ivabradin combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation recurrence in pa- tients with left ventricular diastolic dysfunction | Abstract similar documents |
| K. G. Adamyan, L. G. Tunyan, A. L. Chilingaryan | ||
| "... and randomized into 3 groups to receive ivabradine and amiodarone (22 pts), bisoprolol and amiodarone (22 pts ..." | ||
| Vol 15, No 5 (2019) | Possibilities of Combination of Beta-blockers and Ivabradine in Patients with Stable Angina Pectoris | Abstract similar documents |
| V. V. Kashtalap, O. L. Barbarash, D. Yu. Sedykh, K. E. Krivoshapova, D. P. Tsygankova, O. V. Tsygankova | ||
| "... of angina attacks from 58% to 20% (p=0.001). Therapy with ivabradine (Bravadin) was well tolerated ..." | ||
| Vol 7, No 6 (2011) | COMPARATIVE EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH MODERATE ARTERIAL HYPERTENSION ACCOMPANIED BY TYPE 2 DIABETES | Abstract similar documents |
| E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk | ||
| "... in groups A, B or C. Patients of group A (n=25) received a fixed combination of the original perindopril ..." | ||
| Vol 4, No 5 (2008) | COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS | Abstract similar documents |
| S. N. Tolpygina, S. Y. Martsevich | ||
| "... . Patients were randomized in 2 groups (G1 and G2): G1 patients (n=15) received Zocor 20 mg/day during 6 ..." | ||
| Vol 11, No 1 (2015) | HEART RATE-LOWERING THERAPY IN THE TREATMENT OF CHRONIC HEART FAILURE | Abstract similar documents |
| S. V. Shalaev, L. V. Silicic, O. V. Abaturova | ||
| "... blocker ivabradine are discussed. The evidence-based data on ivabradine use reveal its advantages ..." | ||
| Vol 5, No 6 (2009) | ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN HYPERTENSIVE PATIENTS WITH AMLODIDINE: ORIGINAL DRUG VERSUS GENERIC | Abstract similar documents |
| S. Yu. Martsevich, N. A. Dmitrieva, A. D. Deev, L. A. Sokolova, V. V. Jakusevich, J. V. Lukina, M. A. Maximova, A. V. Zaharova, A. A. Serazhim, V. P. Voronina | ||
| "... were split into 2 groups. Study duration was 10 weeks. Efficacy control, dose correction, addition ..." | ||
| Vol 7, No 1 (2011) | THE CHOICE OF THE DRUG AMLODIPINE FOR THE HYPERTENSION TREATMENT FROM THE STANDPOINT OF ECONOMIC FEASIBILITY | Abstract similar documents |
| S. Yu. Martsevich, N. A. Dmitrieva, A. D. Deev, Yu. V. Lukina, L. A. Sokolova, V. V. Yakusevich | ||
| "... randomized to receive generic (Group 1) or original (Group 2) amlodipine in the initial dose of 5 mg daily ..." | ||
| Vol 7, No 5 (2011) | EFFICACY AND SAFETY OF IVABRADINE AND BISOPROLOL IN PATIENTS WITH ISCHEMIC HEART DISEASE: RESULTS OF COMPARATIVE RANDOMIZED OPEN STUDY | Abstract similar documents |
| R. D. Kurbanov, A. O. Kan, F. M. Bekmetova, A. B. Shek | ||
| "... Aim. To study influence of ivabradine as compared with bisoprolol on clinical and hemodynamic ..." | ||
| Vol 12, No 1 (2016) | Pharmacoeconomic analysis of heart rate slowing drugs in patients with ischemic heart disease | Abstract similar documents |
| E. I. Tarlovskaya, T. I. Chudinovskikh | ||
| "... ) or into group B (received therapy based on of generic bisoprolol). Ivabradine was added, if the effect ..." | ||
| Vol 16, No 2 (2020) | Off-Label Medicines Use: Complex Problem of Modern Clinical Practice | Abstract similar documents |
| S. R. Gilyarevskiy | ||
| Vol 8, No 2 (2012) | THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE | Abstract similar documents |
| S. N. Tereshchenko, I. V. Zhirov, A. G. Kochetov, O. V. Uspenskaya | ||
| "... A comparison of ivabradine and omega-3 polyunsaturated fatty acids, drugs with principally ..." | ||
| Vol 17, No 2 (2021) | Post-COVID Syndrome and Tachycardia: Theoretical Base and Treatment Experience | Abstract similar documents |
| V. I. Podzolkov, A. E. Bragina, A. I. Tarzimanova, L. V. Vasil'eva, E. P. Batrakova, N. V. Lobova, E. E. Bykova, M. M. Khachuroeva | ||
| "... as a treatment for POTS, including the sinus node If channel inhibitor ivabradine. Data from several studies ..." | ||
| Vol 7, No 5 (2011) | COMPARATIVE EFFICACY AND SAFETY OF HYPOLIPIDEMIC THERAPY WITH GENERIC AND ORIGINAL MEDICINAL PRODUCTS OF SIMVASTATIN | Abstract similar documents |
| E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk | ||
| "... into group A or group B. Patients of group A (n=18) received original simvastatin, patients of group B (n=20 ..." | ||
| Vol 7, No 2 (2011) | A COMPARATIVE STUDY OF THE EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN MONOTHERAPY OR IN COMBINATION WITH S-AMLODIPINE AND INDAPAMIDE IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 DEGREES. RESULTS OF THE CLINICAL RANDOMIZED CROSSOVER STUDY | Abstract similar documents |
| S. Yu. Martsevich, S. N. Tolpygina, V. P. Voronina, O. V. Lerman, Yu. V. Lukina, N. A. Dmitrieva, I. V. Vashurina | ||
| "... Hg in group 2 (p<0.001 for both groups), intergroup differences were insignificant. Target BP levels ..." | ||
| Vol 5, No 6 (2009) | ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS | Abstract similar documents |
| N. A. Dmitrieva, S. N. Tolpygina | ||
| "... (АСК) в кардиологической практике. Особое внимание уделяется дженерическим препаратам АСК, применение ..." | ||
| Vol 7, No 2 (2011) | WHAT IS THERAPEUTIC EQUIVALENCE OF GENERIC DRUG AND HOW TO PROVE IT | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, I. V. Vashurina | ||
| "... Обсуждается проблема применения дженерических препаратов в клинической практике и подтверждения их ..." | ||
| Vol 6, No 1 (2010) | COMPARISON OF NEW GENERIC AND ORIGINAL RAMIPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH CARDIOVASCULAR RISK | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, A. A. Serazhim, V. P. Voronina, M. A. Maksimova, L. Yu. Drozdova, A. V. Zakharova | ||
| "... Цель. Сравнить эффективность дженерического препарата рамиприла Хартил® (Эгис) и оригинального ..." | ||
| Vol 4, No 3 (2008) | ESTIMATION OF CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC CARVEDILOLS IN PATIENTS WITH HYPERTENSION OF 1-2 GRADES | Abstract similar documents |
| E. I. Bambysheva, S. N. Tolpygina, D. F. Guranda, I. E. Koltunov, V. G. Belolipetskaja, S. J. Martsevich | ||
| "... . Results. 75 % of Vedikardol-group patients and 75 % of Dilatrend-group patients had reached target BP ..." | ||
| Vol 7, No 1 (2011) | THE ROLE OF MODERN ANTIPLATELET THERAPY IN PREVENTION OF ATHEROTHROMBOSIS: THE IMPORTANCE OF CLOPIDOGREL AND ITS GENERIC DRUGS | Abstract similar documents |
| O. V. Gaisenok | ||
| "... хронология появления дженерических препаратов клопидогрела и перспективы их использования. ..." | ||
| Vol 9, No 5 (2013) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL LOW-DOSE BISOPROLOL/HYDROCHLOROTHIAZIDE COMBINATION IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREES. RESULTS OF CLINICAL RANDOMIZED CROSSOVER STUDY | Abstract similar documents |
| S. Yu. Martsevich, S. N. Tolpygina, A. V. Zakharova, V. P. Voronina, O. V. Lerman, Yu. V. Lukina, N. A. Dmitrieva, N. V. Kiseleva | ||
| "... .6±11.1/10.4±11.3 mm Hg in LODOZ® group and -22.9±9.7/11.7±13.5 mm Hg in BISANGIL® group (p<0 ..." | ||
| Vol 7, No 6 (2011) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA | Abstract similar documents |
| V. P. Voronina, S. N. Tolpygina, N. P. Kutishenko, N. A. Dmitrieva, Yu. V. Lukina, S. Yu. Martsevich | ||
| "... ) were achieved in 10 (71.4%) patients in each group. After 8 weeks of therapy with generic and original ..." | ||
| Vol 8, No 1 (2012) | THE COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL VALSARTAN AS A MONOTHERAPY OR IN COMBINATION WITH HYDROCHLOROTHIAZIDE AND BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREE AND METABOLIC SYNDROME | Abstract similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, V. P. Voronina, L. Yu. Drozdova | ||
| "... Aim. To study the efficacy and safety of generic valsartan Valz (Actavis Group, Iceland ..." | ||
| Vol 5, No 1 (2009) | PROBLEM OF GENERIC REPLACEMENT: ADVANTAGES AND DISADVANTAGES | Abstract similar documents |
| S. N. Tolpygina, S. Yu. Martsevich | ||
| "... Описаны основные различия между оригинальными и дженерическими препаратами (копиями) и приведены ..." | ||
| Vol 8, No 2 (2012) | COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ORIGINAL AND GENERIC ENALAPRIL IN THE ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| O. P. Bobrova, M. M. Petrova | ||
| "... randomized into two groups. Patients of the group 1 received generic enalapril, patients of the group 2 ..." | ||
| Vol 14, No 6 (2018) | Assessment of in Vitro Comparative Dissolution Kinetics of Moxonidine Products as a Factor Potentially Determining Effectiveness of Antihypertensive Treatment | Abstract PDF (Eng) similar documents |
| G. V. Ramenskaya, I. E. Shokhin, N. I. Gaponova, V. R. Abdrakhmanov | ||
| Vol 7, No 1 (2011) | THERAPEUTIC EQUIVALENCE OF ORIGINAL CLOPIDOGREL (PLAVIX) AND ITS GENERIC (EGITROMB). RESULTS OF COMPARATIVE RANDOMIZED CROSS-OVER BLIND STUDY | Abstract similar documents |
| V. V. Yakusevich, A. S. Petrochenko, V. A. Simonov, N. Yu. Levshin, A. D. Deev | ||
| "... препаратов. Заключение. Дженерический препарат Эгитромб (Egis, Венгрия) и оригинальный клопидогрел Плавикс ..." | ||
| Vol 12, No 3 (2016) | ESTIMATION OF RIGHT VENTRICULAR DIASTOLIC FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE IN DIFFERENT AGE GROUPS | Abstract PDF (Eng) similar documents |
| R. A. Gajfulin, A. N. Sumin, O. G. Arhipov | ||
| "... with ischemic heart disease (IHD) in different age groups. Material and methods. Patients (n=678) with IHD aged ..." | ||
| Vol 9, No 5 (2013) | THE PROBLEM OF MEDICINES INTERCHANGEABILITY. FOCUS ON PERINDOPRIL | Abstract similar documents |
| A. I. Malyhina, M. V. Zhuravleva, A. K. Starodubtsev, M. L. Maksimov, O. A. Rogacheva | ||
| "... ) was found in patients of Parnavel group by 28 mm Hg (19%) and 17 mm Hg (19%), respectively. In the patients ..." | ||
| Vol 6, No 6 (2010) | COMBINATION THERAPY OF HYPERTENSION — A RELIABLE WAY TO TARGET ACHIEVE | Abstract similar documents |
| Yu. V. Lukina, S. Yu. Martsevich | ||
| "... was reached respectively in 90% and 97% of patients with HT in groups of generic and original amlodipine ..." | ||
| Vol 8, No 4 (2012) | COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I) | Abstract similar documents |
| S. Y. Martsevich, S. N. Tolpygina | ||
| "... .8±8.4 and -30.4±12.8/18.7±8 mm Hg for groups 1 and 2, respectively , p<0.001 for the both groups ..." | ||
| Vol 10, No 4 (2014) | PHARMACOECONOMIC ANALYSIS OF ANTIHYPERTENSIVE DRUG COMBINATIONS USE | Abstract similar documents |
| E. I. Tarlovskaya, Y. A. Balandina, N. S. Maximchuk-Kolobova | ||
| "... /effectiveness ratio were evaluated. Results. In group A (fixed combination of original enalapril ..." | ||
| Vol 7, No 5 (2011) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, V. A. Egorov, A. V. Zagrebel'nyy, A. A. Serazhim, Yu. V. Lukina, N. A. Dmitrieva | ||
| "... decreased 2 hours after nebivolol intake both single one and after 30 days of treatment (p<0.001). Duration ..." | ||
| Vol 8, No 5 (2012) | COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS AND ERECTILE FUNCTION IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART 2) | Abstract similar documents |
| S. Y. Martsevich, S. N. Tolpigina | ||
| "... into randomized, an open-label comparative stepped trial. The patients were randomized into two groups: the group ..." | ||
| Vol 6, No 2 (2010) | THE MODERN ASPECTS OF CLOPIDOGREL USE | Abstract similar documents |
| E. N. Dankovtseva, D. A. Zateyshchikov | ||
| "... оригинального и дженерического препаратов клопидогрела. ..." | ||
| Vol 16, No 1 (2020) | Deprescribing Antihypertensive Drugs in Patients of Older Age Groups | Abstract similar documents |
| O. D. Ostroumova, M. S. Cherniaeva, D. A. Sychev | ||
| "... guidelines for the treatment of AH determine specific approaches for managing patients of older age groups ..." | ||
| Vol 4, No 1 (2008) | COMPARISON OF ANTIPLATELET EFFECT AND SAFETY OF ORIGINAL DRUG «ASPIRIN CARDIO» AND GENERIC«ACECARDOL» IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE | Abstract similar documents |
| N. A. Belolipetskiy, S. N. Tolpygina, O. А. Litinskaya, V. G. Belolipetskaya, S. Yu. Martsevich | ||
| "... by therapies. There were not significant inter-group differences. Conclusion. ASA generic medicine Acecardol ..." | ||
| Vol 16, No 3 (2020) | A Prospective, Initiative, Single-Center Open Post-Registration Comparative Study of Laboratory Efficacy of Various Forms of Acetylsalicylic Acid in a Cardioprotective Dose with Different Composition of Excipients: Results of the SFAIROS Study | Abstract similar documents |
| N. V. Lomakin, L. I. Buryachkovskaya, D. A. Zolin, V. I. Kazey | ||
| "... . Patients were divided into 3 groups for treatment with one of the three studied drugs: Cardiomagnyl ..." | ||
| Vol 15, No 5 (2019) | Comparative Study of the Results of a Three-year Observation of Cardiologists and Surgeons in Patients with Peripheral Atherosclerosis | Abstract similar documents |
| L. S. Barbarash, A. N. Sumin, Yu. D. Medvedeva, E. V. Korok | ||
| "... group were older than these in the first group (p<0.001). Patients of the group 1 compared to the group ..." | ||
| Vol 13, No 3 (2017) | COMBINED ANTIHYPERTENSIVE THERAPY IN REAL CLINICAL PRACTICE. FOCUS ON FIXED COMBINATIONS OF ANTIHYPERTENSIVE DRUGS (According to the Data of Outpatient Registries RECVASA and PROFILE) | Abstract similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, A. V. Zagrebelnyy, M. M. Loukianov, A. N. Vorobyev, E. A. Pravkina, N. O. Myasnikova | ||
| "... On Behalf of the Working Groups of the Registries PROFILE and REСVASA. Working Group ..." | ||
| Vol 13, No 2 (2017) | OBJECTIVE AND SUBJECTIVE FACTORS OF MEDICAL DRUG CHOICE | Abstract similar documents |
| E. B. Babanskaya, L. V. Menshikova | ||
| "... или дженерических ЛП и факторов, влияющих на этот выбор. Результаты. Большинство респондентов ..." | ||
| Vol 13, No 3 (2017) | SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION | Abstract similar documents |
| S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev | ||
| "... groups with a history of myocardial infarction by the example of outpatient cardiology institution ..." | ||
| Vol 6, No 6 (2010) | WORKING GROUP OF THE YOUNG CARDIOLOGISTS HAS BEEN ESTABLISHED AT THE SOCIETY OF CARDIOLOGY OF THE RUSSIAN FEDERATION | Abstract similar documents |
| "... Working group of the Young Cardiologists has been established at the Society of Cardiology ..." | ||
| Vol 14, No 3 (2018) | THE POSSIBILITIES OF USING A NEW FIXED-DOSE COMBINATION OF ROSUVASTATIN AND ACETYLSALICYLIC ACID: FOCUS GROUPS OF PATIENTS | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, N. Yu. Voevodina, S. S. Sharonova | ||
| Vol 10, No 1 (2014) | ADHERENCE TO LONG-TERM TREATMENT OF CARDIOVASCULAR DISEASE AND NON-COMPLIANCE WITH MEDICAL RECOMMENDATIONS: THE OPINION OF PATIENTS AND PHYSICIANS BY THE RESULTS OF FOCUSED INTERVIEW | Abstract similar documents |
| O. N. Semenova, E. A. Naumova, Yu. G. Schwartz | ||
| "... with adherence to treatment for chronic cardiovascular diseases in the group focused interview of patients ..." | ||
| Vol 19, No 2 (2023) | Clinical Efficacy and Safety of Empagliflozin in Patients with Acute Heart Failure from the First Day of Hospitalization | Abstract similar documents |
| D. P. Golubovskaya, V. N. Karetnikova, A. B. Osokina, I. P. Oleinik, O. L. Barbarash | ||
| "... , only in the main group there was an improvement in all clinical indicators (p<0.01), an increase ..." | ||
| Vol 10, No 3 (2014) | EFFECT OF ANTIVIRAL THERAPY ON HEART AND LIVER HEMODYNAMICS IN PATIENTS WITH VIRAL CIRRHOSIS | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, E. V. Radaeva | ||
| "... %) and 2nd groups (46%) was detected as compared with the control group (p<0.001). Standard deviation ..." | ||
| Vol 9, No 6 (2013) | COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY | Abstract similar documents |
| I. V. Zhirov, G. K. Sarbalinova, S. N. Tereschenko | ||
| "... of the treatments was also assessed. Results. Group 1: the average CHF class (NYHA) decreased by 20.7% (p<0.01), EF ..." | ||
| Vol 14, No 2 (2018) | MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | Abstract similar documents |
| L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov | ||
| "... density cholesterol (LDC) by 52.4% (p<0.001) was found after 24 weeks in Group 1. Achieving the target LDC ..." | ||
| Vol 15, No 3 (2019) | Disorders of the Cardiovascular System in Patients with Chronic Viral Hepatitis | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko | ||
| "... valve in patients of groups 1 and 2 was lower than in the control by 15% and 17%, respectively (p<0.001 ..." | ||
| Vol 13, No 4 (2017) | COMPARATIVE ANALYSIS OF THE EFFICACY OF FIXED-DOSE COMBINATIONS OF AMLODIPINE/LISINOPRIL AND BISOPROLOL/HYDROCHLORTHIAZIDE IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION COMBINED WITH OBESITY AND OVERWEIGHT | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, M. V. Lopukhina | ||
| "... (from 9.3±0.5 to 8.4±0.4 mm Hg; p<0.001) at night. Patients in the amlodipine/lisinopril group compared ..." | ||
| Vol 9, No 1 (2013) | FACTORS EFFECTING THE DECOMPENSATION OF CHRONIC HEART FAILURE IN THE ELDERLY | Abstract PDF (Eng) similar documents |
| V. N. Larina, B. Ya. Bart, E. A. Vartanyan | ||
| "... NYHA class II-IV were enrolled into the study. The first group consisted of 87 (35.1%) patients who ..." | ||
| Vol 6, No 4 (2010) | COMPARISON OF CLINICAL EFFICACY OF ORIGINAL BISOPROLOL AND ITS GENERIC DRUG IN PATIENTS WITH STABLE ANGINA AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Abstract similar documents |
| N. Yu. Grigorieva, E. G. Sharabrin, A. N. Kuznetsov | ||
| "... after 12 weeks of therapy in the 1st group and from 96.9±4.9 to 66.3±5.6 bt/min (р<0.001) in the 2nd ..." | ||
| Vol 11, No 3 (2015) | THE EFFECT OF NEBIVOLOL ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH MILD HYPERTENSION | Abstract similar documents |
| I. L. Tepoyan, D. V. Nebieridze, I. A. Skripnikova, A. S. Safaryan, V. A. Vygodin, V. E. Novikov, L. M. Murashko | ||
| "... in atenolol group this index decreased from -1.5±0.7 SD to -1.6±0.64 SD (p<0.001). When evaluating T-test ..." | ||
| Vol 5, No 5 (2009) | EFFECT OF MITRAL REGURGITATION ON CHRONIC HEART FAILURE COURSE AND STRUCTURE-FUNCTIONAL HEART STATE | Abstract PDF (Eng) similar documents |
| V. N. Larina, B. Y. Bart, M. P. Mikhaylusova, B. N. Mamtsev | ||
| "... relative wall thickness (p=0,021) and LV ejection fraction (p<0,001). Patients of this group were ..." | ||
| Vol 15, No 2 (2019) | Cardiovascular medicine prices as an indicator of access to medicines and their rational use | Abstract similar documents |
| C M. Razzakova, L. E. Ziganshina | ||
| "... каждого наименования изучили цены на оригинальный брендовый препарат и его дженерический аналог по ..." | ||
| Vol 15, No 2 (2019) | Remodeling of the Pulmonary Circulation in Patients with Viral Liver Cirrhosis | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko | ||
| "... - 0.9 [0.8;1.31 ], in the 2nd group - 0.8 [0.78; 1.2] with a control value of 1.6 [1.2;1.94] (p<0.001 ..." | ||
| Vol 18, No 1 (2022) | Omega-3 Polyunsaturated Fatty Acids: the Role in Prevention of Atrial Fibrillation in Patients with Coronary Artery Disease after Coronary Artery Bypass Graft Surgery | Abstract PDF (Eng) similar documents |
| O. A. Rubanenko, Yu. V. Shchukin, L. V. Limareva, T. K. Ryazanova, A. O. Rubanenko, I. L. Davydkin | ||
| "... . Studied were 306 patients divided into two groups: patients of group I didn’t receive PUFAs (158 patients ..." | ||
| Vol 16, No 6 (2020) | Monitoring Cardiovascular Medicine Prices as a Tool for Analyzing the Effectiveness of Government Intervetions to Ensure Access to Medicines at the Regional Level | Abstract similar documents |
| C. M. Razzakova, L. E. Ziganshina | ||
| "... секторе цены на дженерические препараты были на уровне референтных с показателями МОЦР 1,14 [0,41-1,84] и ..." | ||
| Vol 6, No 6 (2010) | NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION | Abstract similar documents |
| E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya | ||
| "... (compensated) of LV remodeling increased by 18% (p<0.001) in group A2, and by 6%, (p=0.03) in group A1. After ..." | ||
| Vol 16, No 4 (2020) | Real-Life International Normalized Ratio Profile in Patients with Non-Valvular Atrial Fibrillation Prescribed Vitamin K Antagonist | Abstract PDF (Eng) similar documents |
| S. I. Farag, O. S. Arafa, A.A. E. Hassan, H. M. Mashhour, A. M. Bendary | ||
| "... .0), and also had fewer comorbidities (mean Charlson index was 0.0; p<0.001) compared to patients in group II ..." | ||
| Vol 9, No 4 (2013) | EFFECT OF IRON AND SELENIUM DRUGS ON DIASTOLIC MYOCARDIAL FUNCTION IN PATIENTS WITH ANEMIC CARDIOMYOPATHY | Abstract similar documents |
| E. V. Goncharova, A. V. Govorin | ||
| "... echocardiography, before and af- ter treatment. Control group contained 16 healthy individuals Results. Disorders ..." | ||
| Vol 20, No 6 (2024) | Сardiac interoception and its link with psychological characteristics in patients with symptomatic and asymptomatic premature ventricular contractions | Abstract similar documents |
| A. S. Limonova, I. A. Minenko, A. A. Sukmanova, K. V. Davtyan, A. I. Ershova, O. M. Drapkina | ||
| "... .003) and the control group (p<0.001). A trend towards higher interoceptive accuracy was found in the group ..." | ||
| Vol 15, No 6 (2019) | Possibilities of PRECISE-DAPT Score for Risk Prediction of Ischemic and Hemorrhagic Events in ST-Elevated Myocardial Infarction (According to the Data of the Registry Study in Kemerovo) | Abstract similar documents |
| D. Yu. Sedykh, V. V. Kashtalap, R. M. Velieva, O. L. Barbarash | ||
| "... or more points) risks groups. Differences in clinical and anamnestic parameters, the peculiarities of DAPT ..." | ||
| Vol 16, No 2 (2020) | Risk Factors, Clinical Features of the Course of Myocardial Infarction and Treatment of Young Patients Based on Two Hospital Registries | Abstract similar documents |
| O. L. Barbarash, D. Yu. Sedykh, I. S. Bykova, V. V. Kashtalap, A. D. Erlich | ||
| "... with myocardial infarction (MI) according to RECORD-3 are more often male smokers (p=0.001) with a heredity ..." | ||
| Vol 6, No 4 (2010) | EFFICACY OF VARIOUS DRUG FORMS OF LYCOPENE IN PATIENTS WITH DYSLIPIDEMIA | Abstract similar documents |
| P. Ya. Dovgalevsky, V. A. Klochkov, N. E. Chalyk, O. M. Ansimova, I. Petyaev | ||
| "... in three groups of patients (n= 27, 25 and 28 respectively) with ischemic heart disease, dyslipidemia ..." | ||
| Vol 14, No 5 (2018) | Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome | Abstract PDF (Eng) similar documents |
| Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal | ||
| "... to atorvastatin and at the same time the rosuvastatin group was safer regarding liver enzymes elevation, p<0.001 ..." | ||
| Vol 15, No 5 (2019) | Patients with History of Myocardial Infarction and Acute Cerebrovascular Accidentin Clinical Practice: Demographic, Clinical Characteristics, Drug Treatment and Outcomes (Data of Outpatient and Hospital Registry REGION) | Abstract similar documents |
| E. Yu. Okshina, M. M. Loukianov, S. Yu. Martsevich, S. S. Yakushin, N. P. Kutishenko, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. V. Kudryashov, S. A. Boytsov, O. M. Drapkina | ||
| "... and a history of MI (group “ACVA+MI” and 1530 patients had ACVA without history of MI (group “ACVA without MI ..." | ||
| Vol 9, No 6 (2013) | EFFECT OF SIMVASTATIN THERAPY ON INDICATORS OF TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE | Abstract similar documents |
| T. V. Pinchuk, Y. N. Fedulaev, G. A. Khairetdinova, A. A. Kozina, V. N. Ryzhenkov, N. M. Ahmedzhanov | ||
| "... ventricular filling velocity at atrial contraction) ratio by 18.7% (p<0.001) was found in the main group ..." | ||
| Vol 18, No 5 (2022) | Clinical and Anamnestic Characteristics, Cardiovascular Pharmacotherapy and Long-term Outcomes in Multimorbid Patients after COVID-19 | Abstract similar documents |
| A. A. Smirnov, M. M. Loukianov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Maltseva, E. N. Belova, V. G. Klyashtorniy, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina | ||
| "... in the CVMM group (80.9%) compared to the group without CVD (36.7%; p<0.001). The frequency of proper ..." | ||
| Vol 18, No 6 (2022) | Evaluation of Fibrosis Markers as a Potential Method for Diagnosing Non-Obstructive Coronary Artery Disease in Patients with Stable Coronary Artery Disease | Abstract similar documents |
| N. N. Pakhtusov, A. O. Yusupova, K. A. Zhbanov, A. A. Shchedrygina, E. V. Privalova, Yu. N. Belenkov | ||
| "... volunteers (p <0.001). There were no significant differences between the main and control groups (p>0 ..." | ||
| Vol 19, No 2 (2023) | Effectiveness of Class IC Antiarrhythmics in Patients with Paroxysmal Form of Atrial Fibrillation in Absence of Structural Heart Disease | Abstract similar documents |
| D. A. Tsaregorodtsev, M. A. Khalikova, S. S. Vasyukov, M. M. Beraya, A. V. Sedov | ||
| "... paroxysms. Patients was divided into the lappaconitine hydrobromide group (LH group; n=26), the propafenone ..." | ||
| Vol 13, No 5 (2017) | IS IT POSSIBLE TO IMPROVE THE ADHERENCE TO TREATMENT OF HYPERTENSION AND DYSLIPIDEMIA IN PATIENTS WITHOUT CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS? | Abstract similar documents |
| A. А. Sarycheva, D. V. Nebieridze, T. V. Kamyshova | ||
| "... .14 vs 1.27 in the control group (p<0.001). In the main group, adherence to antihypertensive therapy ..." | ||
| Vol 6, No 5 (2010) | THE USE OF ATORVASTATIN FOR THE PREVENTION OF RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| S. N. Tereshchenko, N. G. Chuich, A. L. Syrkin, D. A. Andreev, A. V. Kolchurina, V. P. Terentev, A. Yu. Borozinets | ||
| "... cardioversion. Patients were randomized into 2 groups. Patients in Group 1 (n=30) received standard therapy ..." | ||
| Vol 16, No 5 (2020) | Atrial Fibrillation: the Association with Physical Activity and the Effects of Cardiac Rehabilitation | Abstract similar documents |
| M. G. Bubnova, D. M. Aronov | ||
| "... 17.4% of control group patients (p<0.01). Steady growth in the number of patients with AF ..." | ||
| Vol 4, No 3 (2008) | DYNAMICS OF THE HEART RATE VARIABILITY IN PATIENTS WITH ATRIAL FIBRILLATION DURING ATORVASTATIN THERAPY | Abstract similar documents |
| E. S. Kozlova, E. E. Galaktionova, F. A. Nemchuk, Yu. M. Lopatin | ||
| "... and paroxysmal AF were included in the study. Patients were divided into two groups – control group (basic ..." | ||
| Vol 13, No 1 (2017) | CHANGE OF ARRHYTHMIC EVENTS IN ACUTE MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION AFTER PHARMACOINVASIVE REVASCULARIZATION | Abstract similar documents |
| V. E. Oleynikov, E. A. Shigotarova, A. V. Kulyutsin, E. V. Dushina, J. A. Guskova | ||
| "... into the group "without rethrombosis" (RT(–)). Patients (n=33; 28.2%) with CAG proven rethrombosis of the infarct ..." | ||
| Vol 13, No 4 (2017) | OCCURRENCE OF THE METABOLIC SYNDROME AND ITS EFFECT ON CARDIOVASCULAR RISK IN PATIENTS WITH GOUT | Abstract similar documents |
| I. I. Polskaya, I. M. Marusenko, T. I. Kulagina, N. N. Vezikova | ||
| "... and hypertriglyceridemia was similar in the compared groups of patients with MS regardless of the presence of gout (p<0.001 ..." | ||
| Vol 17, No 1 (2021) | Comparative Assessment of the Clinical Course, Drug Therapy and Outcomes in Myocardial Infarction without or with Obstructive Coronary Artery Disease | Abstract similar documents |
| O. A. Fomina, S. S. Yakushin | ||
| "... of double antiplatelet therapy: (99.0% vs 80.6% р< 0.01) in MIOCA patients. In the MINOCA group а more ..." | ||
| Vol 6, No 4 (2010) | HEART RATE VARIABILITY IN PATIENTS WITH PREVIOUS Q-WAVE MYOCARDIAL INFARCTION IN DIFFERENT TREATMENT SCHEMES IN EARLY POSTINFARCTION PERIOD | Abstract PDF (Eng) similar documents |
| A. A. Abdullaev, R. M. Gafurova, U. A. Islamova, I. A. Kadieva, R. G. Khabchabov | ||
| "... to the first and to control groups. In the second group LF increased from 223.8±56.2 to 734±90.9 мs2 (p<0.001 ..." | ||
| Vol 13, No 5 (2017) | COMORBIDITIES IN PATIENTS WITH ISCHEMIC HEART DISEASE: GENDER DIFFERENCES | Abstract similar documents |
| A. N. Sumin, E. V. Korok, A. V. Shcheglova, O. L. Barbarash | ||
| "... into the study. All the patients were divided into 2 groups depending on the gender: Group 1 – 147 females, Group ..." | ||
| Vol 20, No 2 (2024) | Long-term effects of enhanced external counterpulsation in the management of patients with ischemic chronic heart failure | Abstract similar documents |
| A. S. Lishuta, O. A. Slepova, N. A. Nikolaeva, M. F. Petruhnova, E. V. Privalova, Yu. N. Belenkov | ||
| "... from 2.41±0.49 initially to 1.95±0.47 after 24 months (p<0.001), and in group 2 from 2.37±0.49 to 2 ..." | ||
| Vol 6, No 5 (2010) | EFFECT OF BETA-BLOCKERS ON BLOOD PRESSURE, PERIOPERATIVE COMPLICATIONS AND HOSPITAL STAY DURATION IN PATIENTS WITH INTERMEDIATE RISK OF CARDIOVASCULAR COMPLICATIONS AFTER ROUTINE CHOLECYSTECTOMY: AN OPEN COMPARATIVE RANDOMIZED STUDY | Abstract similar documents |
| O. L. Barbarash, R. V. Repnikova, T. V. Shoforus, O. I. Golofaeva | ||
| "... .1 min-1) than in group 2 (74,5±8,2 and 73,9±7,0 min-1, respectively, p<0,001 for both periods ..." | ||
| Vol 5, No 2 (2009) | COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Veliganina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiselev, S. Yu. Levashov, V. A. Nevzorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnjukova, V. V. Yakusevich | ||
| "... ,26±0,10kg/m2 (р<0,01) in metoprolol group. Carvedilol in comparison with metoprolol had more positive ..." | ||
| Vol 6, No 1 (2010) | ANTIHYPERTENSIVE EFFICACY OF VALSARTAN IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION: THE FIRST RESULTS OF RUSSIAN MULTICENTER OPEN STUDY | Abstract similar documents |
| V. I. Podzolkov, V. A. Bulatov, A. V. Vigdorchik | ||
| "... . Results. Significant decrease of SBP and DBP was observed in each group between the 1st and 5th visits ..." | ||
| Vol 10, No 5 (2014) | DUAL ANTIPLATELET THERAPY IN THE REAL CLINICAL PRACTICE | Abstract similar documents |
| G. N. Guseva, T. V. Pavlova, I. L. Voronova, S. M. Chohlunov | ||
| "... антитромбоцитарных препаратов, при этом отдавали предпочтение дженерическим препаратам клопидогрела. ..." | ||
| Vol 10, No 5 (2014) | STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE | Abstract similar documents |
| L. N. Malay | ||
| "... результаты российских исследований по терапевтической эквивалентности дженерического препарата с оригинальным ..." | ||
| Vol 13, No 3 (2017) | ROLE OF PULMONARY HYPERTENSION IN THE DEVELOPMENT OF CIRRHOTIC CARDIOMYOPATHY | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, E. V. Radaeva | ||
| "... with the control-group (p<0.001). The revealed abnormalities especially increased in patients with PH, they also ..." | ||
| Vol 15, No 1 (2019) | Prognostic Value of ECG in Patients with Pulmonary Embolism | Abstract similar documents |
| I. S. Mullova, T. V. Pavlova, S. M. Khokhlunov, D. V. Duplyakov | ||
| "... , dysfunction of the right ventricle. 443 patients (93.9%) without fatal outcome were the first group and 29 ..." | ||
| Vol 6, No 1 (2010) | EFFICACY OF PHYSICAL TRAINING AND ANALYSIS OF LIPID-LOWERING THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER ACUTE CORONARY INCIDENTS | Abstract PDF (Eng) similar documents |
| D. M. Aronov, V. B. Krasnitskij, M. G. Bubnova | ||
| "... % (p<0.001) in the main group. Decrease in total cholesterol (TC) by -3.6% (p<0.05) and increase ..." | ||
| Vol 12, No 4 (2016) | Morphometric changes of the left ventricle and characteristics of peripheral hemodynamics in patients with drug resistant hypertension | Abstract similar documents |
| R. R. Kushkhova, A. G. Avtandilov | ||
| "... (LVMI) in patients in Group 1 was 134.0±6,5g/m² vs 98.4±3.3 g/m² in Group 2 (p<0.001). LVMI in men ..." | ||
| Vol 18, No 6 (2022) | Adherence to Visits to Medical Institutions and Quality of Therapy after Acute Coronary Syndrome (according to the LIS Registry 3) | Abstract similar documents |
| N. P. Zolotareva, A. V. Zagrebelny, M. L. Ginzburg, S. Yu. Martsevich, O. M. Drapkina | ||
| "... <0.001) and antiplatelets (90.9%, p=0.001). In both groups, committed and not committed to attending ..." | ||
| Vol 18, No 5 (2022) | The Role of Structured Telephone Support in the Development of Self-care in Comorbid Patients with Chronic Heart Failure | Abstract PDF (Eng) similar documents |
| E. D. Kartamysheva, Yu. M. Lopatin | ||
| "... .7% in the comparison group (p<0.001). A significant maximum improvement in the score was noted in section B ..." | ||
| Vol 9, No 4 (2013) | URAPIDIL: MODERN MEDICINE FOR THE TREATMENT OF HYPERTENSIVE CRISES | Abstract similar documents |
| A. V. Melekhov, Yu. I. Ostrovskaya | ||
| "... into the study. Patients were randomized into two groups: standard treatment (n=20) or urapidil treatment (n=66 ..." | ||
| Vol 18, No 1 (2022) | Preventive Screening of Young People from the Perspective of Vascular Aging Phenotypes: the Role of Body Weight | Abstract similar documents |
| M. Y. Evsevyeva, M. V. Eremin, M. V. Rostovtseva, O. V. Sergeeva, A. V. Rusidi, V. D. Kudryavtseva, E. V. Shchetinin | ||
| "... was performed with evaluating of CAVI. All subjects were divided into tertile groups for this indicator, taking ..." | ||
| 1 - 100 of 832 Items | 1 2 3 4 5 6 7 8 9 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
